Arachnoiditis Treatment Market: Rise in number of spinal surgeries to drive the market

Arachnoid is a thin and transparent membrane, also known as meninges, which protects the nerves of the spinal cord.

Arachnoiditis Treatment Market: Introduction

Arachnoid is a thin and transparent membrane, also known as meninges, which protects the nerves of the spinal cord. Inflammation of the arachnoid results in a pain disorder, which leads to arachnoiditis. The inflammation occurs due to irritation from spine injury, chemicals, infections, compression in the spinal nerves, or post spine surgical complications. The inflammation results into scar tissue and adhesions, which cause nerves to stick together and cause arachnoiditis. Symptoms of arachnoiditis include numbness, tingling, burning pain in lower legs, and this rare condition causes paralysis in the legs in some people.

Arachnoiditis causes severe and chronic pain, and neurological deficits, and the symptoms vary from mild to severe. The pattern of the condition is unpredictable; however, it depends on symptoms, severity, and progression. Age and mild neurological symptoms could worsen arachnoiditis and result in paralysis. Arachnoiditis is quite common in people aged between 40 and 60. It is a rare condition and the risk factors include diabetes, alcoholism, AIDS, chemotherapy, and organ transplantation. Prevalence of arachnoiditis is low; however, an estimated 25,000 cases occur every year in North & South America, Asia, and Europe.

Request Brochure for Report –

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=76649

Key Drivers and Restraints of Global Arachnoiditis Treatment Market

Rise in number of spinal surgeries, increase in incidence of bacterial & viral spinal infections, surge in pain relief procedures, awareness & understanding about arachnoiditis, and adoption of novel treatments are the major drivers of the global arachnoiditis treatment market. Moreover, increase in the geriatric population is a major factor propelling the global arachnoiditis treatment market. Technological advancements and awareness about proper diagnosis are likely to augment the global arachnoiditis treatment market. Adoption of various diagnostic tools such as inflammatory markers and magnetic resonance imaging (MRI) are likely to drive the global market.

Initiatives taken by governments and various organizations to spread awareness about arachnoiditis are also anticipated to boost the growth of the global arachnoiditis treatment market. For instance, the State of Michigan declared Arachnoiditis Awareness Month every year, with a goal of creating maximum awareness about the disease and its treatment. These factors are projected to fuel the growth of the global arachnoiditis treatment market. Strong research & development, increase in diagnosis rate, and technological advancements are the other drivers of the global market.

Request for Analysis of COVID19 Impact on Arachnoiditis Treatment Market –

https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=76649

The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.

Pre-book Arachnoiditis Treatment Market Report –

https://www.transparencymarketresearch.com/checkout.php?rep_id=76649&ltype=S

Key Players Operating in Global Arachnoiditis Treatment Market

The global arachnoiditis treatment market is fragmented, with the presence of a number of large and small players. Major players in the global arachnoiditis treatment market are:

  • Baxter
  • B. Braun Melsungen AG
  • Pfizer, Inc.
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Sandoz International GmbH
  • Takeda Pharmaceutical Company Limited
  • Novartis AG
  • Others

About Us

Transparency Market Research is a global market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for several decision makers. Our experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts so that it always reflects latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Contact

Mr. Rohit Bhisey

Transparency Market Research,

90 State Street, Suite 700,

Albany, NY 12207

Tel: +1-518-618-1030

USA - Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com/